Author

K. E. Dooley

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2

Frequent Co-Authors

E. Nuermberger· 3 shared R. Tasneen· 2 shared A. Garcia· 1 shared A. Kaushik· 1 shared A. Vernon· 1 shared E. V. Kurbatova· 1 shared J. E. Stout· 1 shared J. Lee· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

E. Nuermberger

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Novel regimens of bedaquiline-pyrazinamide combined with moxifloxacin, rifabutin, delamanid and/or OPC-167832 in murine tuberculosis models

E. Nuermberger, R. Tasneen, A. Garcia, P. J. Converse, M. D. Zimmerman, V. A. Dartois, E. V. Kurbatova, A. Vernon, W. Carr, J. E. Stout, K. E. Dooley

This paper tests novel tuberculosis treatment regimens in mice, finding that BZM-based regimens show improved sterilizing activity compared to standard care.

bioRxiv · Dec 21, 2021Microbiology

In vitro activity of bedaquiline and imipenem against actively growing, nutrient-starved, and intracellular Mycobacterium abscessus

O. Martins, N. Ammerman, J. Lee, A. Kaushik, K. E. Dooley, E. Nuermberger

This study evaluates the in vitro activity of bedaquiline and imipenem against M. abscessus under different growth conditions, finding varying interactions between the drugs.

bioRxiv · Aug 6, 2021Microbiology

Preserved efficacy and reduced toxicity with intermittent linezolid dosing in combination with bedaquiline and pretomanid in a murine TB model

K. M. Bigelow, R. Tasneen, Y. S. Chang, K. E. Dooley, E. Nuermberger

bioRxiv · Jun 10, 2020Pharmacology & Toxicology